Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine

NCT03525119 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL: TDV
BIOLOGICAL: HAV Vaccine
BIOLOGICAL: TDV Placebo
BIOLOGICAL: HAV Vaccine Placebo

Sponsor

Takeda